Article
Modifying impact of RET gene haplotypes on medullary thyroid carcinoma clinical course.
Endocrine-related cancer - 1 Apr 2018
Kaczmarek-Ryś Marta, Ziemnicka Katarzyna, Pławski Andrzej, Budny Bartłomiej, Michalak Michał, Hryhorowicz Szymon, Hoppe-Gołębiewska Justyna, Boruń Paweł, Gołąb Monika, Czetwertyńska Małgorzata, Sromek Maria, Szalata Marlena, Ruchała Marek, Słomski Ryszard
Abstract excerpt
The clinical course of medullary thyroid carcinoma (MTC) associated with the MEN2A syndrome as well as of sporadic MTC shows considerable heterogeneity. The disease picture varies not only between the same RET proto-oncogene mutation carriers but also among sporadic MTC patients with no RET germinal mutations, which suggests the involvement of additional modulators of the disease. However, genetic factors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
